Brian K Flesner

Brian K Flesner

University of Missouri

H-index: 8

North America-United States

About Brian K Flesner

Brian K Flesner, With an exceptional h-index of 8 and a recent h-index of 7 (since 2020), a distinguished researcher at University of Missouri, specializes in the field of Comparative Oncology, Chemotoxicity, Osteosarcoma, Cancer Pain.

His recent articles reflect a diverse array of research interests and contributions to the field:

Next-generation sequencing-based liquid biopsy may be used for detection of residual disease and cancer recurrence monitoring in dogs

Clinical validation of a blood-based liquid biopsy test integrating cell-free DNA quantification and next-generation sequencing for cancer screening in dogs

Study Design and Interim Analysis of the Cancer Lifetime Assessment Screening Study in Canines (CLASSiC): The First Prospective Cancer Screening Study in Dogs Using Next …

Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma

Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia

Metagenomic analysis of DNA viruses with targeted sequence capture of canine lobular orbital adenomas and normal conjunctiva

Resolution of paraneoplastic hypoglycemia following nephroureterectomy for treatment of canine renal cell carcinoma: Case report

PET/CT

Brian K Flesner Information

University

Position

Assistant Professor

Citations(all)

226

Citations(since 2020)

203

Cited By

58

hIndex(all)

8

hIndex(since 2020)

7

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Brian K Flesner Skills & Research Interests

Comparative Oncology

Chemotoxicity

Osteosarcoma

Cancer Pain

Top articles of Brian K Flesner

Next-generation sequencing-based liquid biopsy may be used for detection of residual disease and cancer recurrence monitoring in dogs

American Journal of Veterinary Research

2023/12/28

Brian K Flesner
Brian K Flesner

H-Index: 4

Clinical validation of a blood-based liquid biopsy test integrating cell-free DNA quantification and next-generation sequencing for cancer screening in dogs

Journal of the American Veterinary Medical Association

2024/2/7

Brian K Flesner
Brian K Flesner

H-Index: 4

Study Design and Interim Analysis of the Cancer Lifetime Assessment Screening Study in Canines (CLASSiC): The First Prospective Cancer Screening Study in Dogs Using Next …

bioRxiv

2024

Brian K Flesner
Brian K Flesner

H-Index: 4

Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma

Frontiers in Veterinary Science

2024

Brian K Flesner
Brian K Flesner

H-Index: 4

Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia

Journal of veterinary internal medicine

2023/11

Brian K Flesner
Brian K Flesner

H-Index: 4

Metagenomic analysis of DNA viruses with targeted sequence capture of canine lobular orbital adenomas and normal conjunctiva

Microorganisms

2023/4/28

Resolution of paraneoplastic hypoglycemia following nephroureterectomy for treatment of canine renal cell carcinoma: Case report

Frontiers in Veterinary Science

2023/3/31

PET/CT

Canine Osteosarcoma as a Model in Comparative Oncology: Advances and Perspective

2023/3/3

Brian K Flesner
Brian K Flesner

H-Index: 4

Comparative oncology assessment of a novel inhibitor of valosin-containing protein in tumor-bearing dogs

Molecular cancer therapeutics

2022/10/7

Fracture rate and time to fracture in dogs with appendicular osteosarcoma receiving finely fractionated compared to coarsely fractionated radiation therapy: A single …

Veterinary Medicine and Science

2022/5

Brian K Flesner
Brian K Flesner

H-Index: 4

Biodistribution and image characteristics of 124I‐positron emission tomography in dogs with neuroendocrine neoplasia

Veterinary Radiology & Ultrasound

2022/5

Brian K Flesner
Brian K Flesner

H-Index: 4

Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The …

PLoS One

2022/4/26

Brian K Flesner
Brian K Flesner

H-Index: 4

Paired 18F-Fluorodeoxyglucose (18F-FDG), and 64Cu-Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (64Cu-ATSM) PET Scans in Dogs with …

Radiation Research

2022/3/1

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs

Journal of Veterinary Internal Medicine

2022/1

Considerations related to the use of molecular diagnostic tests in veterinary clinical and regulatory practice

Journal of the American Veterinary Medical Association

2021/9/15

Brian K Flesner
Brian K Flesner

H-Index: 4

Philip J Johnson
Philip J Johnson

H-Index: 20

Nasal angiofibroma treatment outcome using intensity‐modulated radiation therapy in a dog

Veterinary Radiology & Ultrasound

2021/7

Adjuvant sirolimus does not improve outcome in pet dogs receiving standard-of-care therapy for appendicular osteosarcoma: a prospective, randomized trial of 324 dogs

Clinical Cancer Research

2021/6/1

Brian K Flesner
Brian K Flesner

H-Index: 4

A 3D-printed Apparatus for Imaging Multiple Rats Simultaneously

Comparative Medicine

2021/4/1

Brian K Flesner
Brian K Flesner

H-Index: 4

A pilot study of cancer-induced bone pain using validated owner questionnaires, serum N-telopeptide concentration, kinetic analysis, and PET/CT

Frontiers in Veterinary Science

2021/12/16

Brian K Flesner
Brian K Flesner

H-Index: 4

Solitary osseous plasmacytomas in dogs: 13 cases (2004–2019)

Journal of Small Animal Practice

2021/12

See List of Professors in Brian K Flesner University(University of Missouri)

Co-Authors

academic-engine